Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Sanders Morris Harris LLC Sells 18,921 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Hamlin Capital Management LLC - Markets Daily
NewEdge Advisors LLC Buys 5,648 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV is Hamlin Capital Management LLC's 7th Largest Position - Stock Observer
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now - AOL
AbbVie (NYSE:ABBV) Stock Price Down 2.5% - Here's What Happened - Markets Daily
Prediction: AbbVie Will End The Year at This Price
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout
Canandaigua National Bank & Trust Co. Acquires New Stake in AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Raised to "Buy" at Erste Group Bank - Daily Political
AbbVie (ABBV) Wins FDA Review For BOTOX Cosmetic In Jawline Treatment Push
ABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset
Allergan Aesthetics Seeks Fifth FDA Approval For BOTOX Cosmetic In Facial Contouring
AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
AbbVie Inc. $ABBV is Meadowbrook Wealth Management LLC's 7th Largest Position - Zolmax
Neville Rodie & Shaw Inc. Sells 17,684 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Holdings Trimmed by Meadowbrook Wealth Management LLC
UBRELVY® (ubrogepant) Recommended for Reimbursement by Canada's Drug Agency (CDA-AMC) for Acute Migraine Treatment
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
Best Biotech Stocks To Watch Today - August 4th - Daily Political
CX Institutional Decreases Position in AbbVie Inc. $ABBV
Edgestream Partners L.P. Sells 58,230 Shares of AbbVie Inc. $ABBV - Daily Political
Navigating evidence-based recommendations for the management of systemic sclerosis
AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's What Happened
AbbVie's Growth Now Leans On A Single Molecule
What Are Wall Street Analysts' Target Price for AbbVie Stock?
AbbVie Earnings: Maintaining Our Fair Value Estimate Following a Steady Second Quarter | Morningstar
AbbVie (NYSE:ABBV) Given New $285.00 Price Target at Cantor Fitzgerald - Markets Daily
AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says
3 Top Dividend Stocks to Buy Before Their Next Payout
Sapient Capital LLC Has $44.56 Million Stake in AbbVie Inc. $ABBV
Best Pharmaceutical Stocks To Follow Today - August 2nd - Markets Daily
ABBV Stock: Q2 Dip Is a Buying Opportunity With $300 Ahead
AbbVie Quietly Solved Its Biggest Problem-Now What?
Best Biotech Stocks To Add to Your Watchlist - August 2nd - Stock Observer
Flagship Wealth Advisors LLC Reduces Stock Holdings in AbbVie Inc. $ABBV
First Nebraska Trust Co Buys Shares of 7,118 AbbVie Inc. $ABBV
Financial Solutions Advisory Group Inc. Purchases New Stake in AbbVie Inc. $ABBV - Markets Daily
9,761 Shares in AbbVie Inc. $ABBV Purchased by Financial Solutions Advisory Group Inc.
AbbVie (NYSE:ABBV) Shares Down 2.4% - What's Next? - Daily Political
AbbVie Adjusts 2026 Profit Outlook After $10.9 Billion Apogee Buy, Reports Strong Q2 Results, ETPharma
Best Pharmaceutical Stocks To Keep An Eye On - July 29th - Markets Daily
4,955 Shares in AbbVie Inc. $ABBV Purchased by Montchanin Asset Management LLC
Segall Bryant & Hamill LLC Takes $43.63 Million Position in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Posts Earnings Results, Beats Estimates By $0.04 EPS - Daily Political
AbbVie Inc. $ABBV Shares Acquired by Capasso Planning Partners LLC - Daily Political
Glenmede Trust Co. NA Has $74.19 Million Stake in AbbVie Inc. $ABBV - Daily Political
Why AbbVie Stock Slumped Today
AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - Zolmax
AbbVie (NYSE:ABBV) Announces Earnings Results, Beats Estimates By $0.05 EPS - Zolmax
AbbVie's Skyrizi and Rinvoq Launches Support Lengthy Patent Protection and a Wide Moat | Morningstar
AbbVie (NYSE:ABBV) Releases Earnings Results, Beats Estimates By $0.05 EPS
AbbVie (NYSE:ABBV) Stock Price Down 2.4% - Time to Sell? - Zolmax
Health Care Down on Rotation Out of Defense - Health Care Roundup | Morningstar
AbbVie (NYSE:ABBV) Trading Down 2.4% - Should You Sell?
AbbVie Inc (ABBV) (Q2 2026) Earnings Call Highlights: Robust Growth Driven by Skyrizi and ...
XLV vs. IHE: Which Healthcare ETF Is the Better Buy?
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?
AbbVie Q2 Earnings Call Highlights
AbbVie Beats but Cuts Guidance on $10.9 Billion Acquisition
Best Medical Stocks To Follow Now - July 31st - Stock Observer
AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps | Morningstar
AbbVie shares fall on earnings miss and weak guidance
AbbVie Trims FY26 Adj. EPS Outlook - Update
AbbVie Profit Rises In Q2
AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates
AbbVie (NYSE:ABBV) Issues Q3 2026 Earnings Guidance - Stock Observer
Pharmaceutical Stocks To Add to Your Watchlist - July 31st - Daily Political
AbbVie Q2 26 Earnings Conference Call At 9:00 AM ET
AbbVie Inc. $ABBV Shares Sold by Vestor Capital LLC
AbbVie Inc. $ABBV Shares Purchased by Groupe la Francaise
FinArc Investments Inc. Makes New Investment in AbbVie Inc. $ABBV
Western Wealth Management LLC Grows Stock Position in AbbVie Inc. $ABBV - Stock Observer
FinArc Investments Inc. Takes $1.15 Million Position in AbbVie Inc. $ABBV - Stock Observer
AbbVie News | Markets Insider
Friday's big stock stories: What's likely to move the market in the next trading session
AbbVie (NYSE:ABBV) Stock Price Down 2.2% - Here's Why
Best Pharmaceutical Stocks To Research - July 30th - Stock Observer
AbbVie Inc. $ABBV Shares Acquired by Hamilton Wealth LLC
Bank of America Corp DE Reduces Stock Position in AbbVie Inc. $ABBV - Markets Daily
Bank of America Corp DE Trims Position in AbbVie Inc. $ABBV - Stock Observer
Pharmaceutical Stocks To Watch Today - July 27th - Daily Political
Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
AbbVie News
S&P 500 Forecast and Predictions for 2026, 2027 and 2030, Can US Stocks Find a Second Wind?
Broadcom (AVGO) Stock Forecast 2026–2030: Can AI Growth Drive Further Gains?
Broadcom AVGO Stock Analysis 2026: Can AI Growth Justify the Price?
Morning Report:Middle east tensions ease, US jobs on the lookout
Latest news
Show more
Gold Price Today, August 7: XAU/USD Holds Near $4,250 Before US Jobs Report
Western Digital Stock Falls 13% and Sandisk Slides 7% as Guidance Disappoints
SpaceX Stock Jumps 6% on $100 Billion Unlock Day as Earlier Selloff Absorbs Supply Shock
Alphabet Stock Falls as AI Leadership Changes and $25 Billion Bond Sale Raise Spending Questions
AVGO Stock News Today: Broadcom Gains as AI Chip Momentum and September Earnings Move Into Focus
